PofoliaShared via Pofolia

Genome Research· 2012Q1· Preprint

Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis

Heidi H. Kong, Julia Oh, Clay Deming, Sean Conlan et al.

Short summary

Skin microbial diversity in children with atopic dermatitis (AD) is lower during flares, especially without recent treatment, and treatment diversifies bacteria, preceding disease improvement.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Skin microbial communities in AD patients are distinct from controls, especially at disease sites.
  • Microbial diversity is reduced during AD flares, and is lower with no recent treatment compared to intermittent treatment.
  • Treatment diversifies skin bacteria, and this diversification precedes clinical improvement in AD.
  • Staphylococcus aureus proportion increases during flares and correlates with disease severity, while S. epidermidis also increases.

AI-generated from the title and abstract; the full text is not read.

Abstract

Atopic dermatitis (AD) has long been associated with Staphylococcus aureus skin colonization or infection and is typically managed with regimens that include antimicrobial therapies. However, the role of microbial communities in the pathogenesis of AD is incompletely characterized. To assess the relationship between skin microbiota and disease progression, 16S ribosomal RNA bacterial gene sequencing was performed on DNA obtained directly from serial skin sampling of children with AD. The composition of bacterial communities was analyzed during AD disease states to identify characteristics associated with AD flares and improvement post-treatment. We found that microbial community structures at sites of disease predilection were dramatically different in AD patients compared with controls. Microbial diversity during AD flares was dependent on the presence or absence of recent AD treatments, with even intermittent treatment linked to greater bacterial diversity than no recent treatment. Treatment-associated changes in skin bacterial diversity suggest that AD treatments diversify skin bacteria preceding improvements in disease activity. In AD, the proportion of Staphylococcus sequences, particularly S. aureus, was greater during disease flares than at baseline or post-treatment, and correlated with worsened disease severity. Representation of the skin commensal S. epidermidis also significantly increased during flares. Increases in Streptococcus, Propionibacterium, and Corynebacterium species were observed following therapy. These findings reveal linkages between microbial communities and inflammatory diseases such as AD, and demonstrate that as compared with culture-based studies, higher resolution examination of microbiota associated with human disease provides novel insights into global shifts of bacteria relevant to disease progression and treatment.

The authors' abstract, as published at the source. Genome Research, 2012 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Dermatology

DermatologyMedicine